Zacks Investment Research upgraded shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a hold rating to a buy rating in a research report report published on Tuesday morning. Zacks Investment Research currently has $64.00 price objective on the stock.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

Several other equities analysts have also recently commented on USPH. Jefferies Group LLC set a $65.00 price target on shares of U.S. Physical Therapy and gave the company a hold rating in a report on Friday, August 4th. Cantor Fitzgerald assumed coverage on shares of U.S. Physical Therapy in a report on Monday, July 24th. They set an overweight rating and a $72.00 price target on the stock. Barrington Research upgraded shares of U.S. Physical Therapy from a market perform rating to an outperform rating and set a $68.00 price target on the stock in a report on Monday, July 3rd. Finally, BidaskClub cut shares of U.S. Physical Therapy from a sell rating to a strong sell rating in a report on Sunday, July 16th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. The stock currently has an average rating of Hold and a consensus target price of $67.25.

U.S. Physical Therapy (NYSE USPH) opened at 59.80 on Tuesday. The company has a 50 day moving average price of $61.21 and a 200 day moving average price of $64.84. The stock has a market capitalization of $752.34 million, a price-to-earnings ratio of 37.85 and a beta of 1.08. U.S. Physical Therapy has a 12 month low of $51.96 and a 12 month high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.60 by $0.01. U.S. Physical Therapy had a net margin of 5.65% and a return on equity of 12.91%. The company had revenue of $104.25 million for the quarter, compared to analysts’ expectations of $102.93 million. Equities research analysts predict that U.S. Physical Therapy will post $2.13 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “U.S. Physical Therapy, Inc. (USPH) Raised to “Buy” at Zacks Investment Research” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/09/02/u-s-physical-therapy-inc-usph-raised-to-buy-at-zacks-investment-research.html.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 8th. Investors of record on Monday, August 21st will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 1.34%. The ex-dividend date is Thursday, August 17th. U.S. Physical Therapy’s payout ratio is presently 46.78%.

In related news, Director Bernard A. Harris, Jr. sold 5,000 shares of U.S. Physical Therapy stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $62.00, for a total value of $310,000.00. Following the completion of the sale, the director now owns 26,422 shares of the company’s stock, valued at approximately $1,638,164. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Glenn Mcdowell sold 1,664 shares of U.S. Physical Therapy stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $59.91, for a total transaction of $99,690.24. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,266 shares of company stock valued at $801,134. 3.10% of the stock is owned by company insiders.

Several large investors have recently added to or reduced their stakes in USPH. Teachers Advisors LLC raised its stake in U.S. Physical Therapy by 3.1% in the fourth quarter. Teachers Advisors LLC now owns 28,963 shares of the company’s stock valued at $2,033,000 after buying an additional 882 shares during the last quarter. Louisiana State Employees Retirement System raised its stake in U.S. Physical Therapy by 2.0% in the first quarter. Louisiana State Employees Retirement System now owns 5,100 shares of the company’s stock valued at $333,000 after buying an additional 100 shares during the last quarter. Wells Fargo & Company MN raised its stake in U.S. Physical Therapy by 5.5% in the first quarter. Wells Fargo & Company MN now owns 44,458 shares of the company’s stock valued at $2,903,000 after buying an additional 2,335 shares during the last quarter. Great West Life Assurance Co. Can raised its stake in U.S. Physical Therapy by 6.4% in the first quarter. Great West Life Assurance Co. Can now owns 17,193 shares of the company’s stock valued at $1,122,000 after buying an additional 1,029 shares during the last quarter. Finally, CT Mason raised its stake in U.S. Physical Therapy by 8.0% in the first quarter. CT Mason now owns 50,612 shares of the company’s stock valued at $3,305,000 after buying an additional 3,750 shares during the last quarter. 95.50% of the stock is owned by institutional investors and hedge funds.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.